34 results
8-K
EX-1.1
NRBO
NeuroBo Pharmaceuticals Inc
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
to environmental laws and regulations.
(j) Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial … governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health
424B4
NRBO
NeuroBo Pharmaceuticals Inc
7 Nov 22
Prospectus supplement with pricing info
9:07am
or in an amount adequate to satisfy any liability that may arise.
If we or our third-party manufacturers fail to comply with environmental, health and safety laws … against potential liabilities. Compliance with applicable environmental, health and safety laws and regulations is expensive, and current or future
8-K
EX-10.3
98saivn qx9wl
14 Sep 22
Entry into a Material Definitive Agreement
5:11pm
D
otolqzukml qly
18 Oct 21
$14M in equity / options / securities to be acquired, sold $14M, 12 investors
11:01am
8-K
EX-10.1
mnweqtxegeak m8ov1ju
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
D
alaom
1 Feb 21
$10M in equity / options / securities to be acquired, sold $10M, 10 investors
4:18pm
8-K
EX-10.1
73d3uubo qah2d
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
D
to54m
12 Jan 21
$17.03M in equity, sold $17.03M, 34 investors
2:22pm
8-K
EX-2.1
5ppy 5exuuf
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-10.1
6m0l ygovmh9
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm